|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/36 | (2006.01) |
| A61K 38/00 | (2013.01) | ||
| C07K 14/745 | (2013.01) | ||
| C07K2319/00 | (2013.01) | ||
| C07K2319/31 | (2013.01) | ||
| C07K 14/755 | (2013.01) | ||
| A61K 38/37 | (2013.01) | ||
| A61P 7/04 | (2018.01) | ||
| C12N 15/62 | (2013.01) |
| (11) | Number of the document | 3458085 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17724760.8 |
| Date of filing the European patent application | 2017-04-26 | |
| (97) | Date of publication of the European application | 2019-03-27 |
| (45) | Date of publication and mention of the grant of the patent | 2022-12-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2017/059976 |
| Date | 2017-04-26 |
| (87) | Number | WO 2017/198435 |
| Date | 2017-11-23 |
| (30) | Number | Date | Country code |
| 16170690 | 2016-05-20 | EP |
| (72) |
KANNICHT, Christoph , DE
SOLECKA-WITULSKA, Barbara , DE
WINGE, Stefan , SE
SCHWIENTEK, Tilo , DE
|
| (73) |
Octapharma AG ,
Seidenstrasse 2, 8853 Lachen,
CH
|
| (54) | GLYCOSYLATED VWF FUSION PROTEINS WITH IMPROVED PHARMACOKINETICS |
| GLYCOSYLATED VWF FUSION PROTEINS WITH IMPROVED PHARMACOKINETICS |